Patrick J. O'brien

Radiology

7505 Metro Blvd Ste 400
Minneapolis, MN 55439

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma.

An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 20, 2023

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis.

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis.

Journal: Blood advances

Published: April 08, 2022

Showing 1-2 of 2

Last Updated: 09/26/2026